Navigation Links
Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board

CAMBRIDGE, Mass., May 1, 2015 /PRNewswire/ -- Portal Instruments, Inc., an emerging leader in the development of innovative drug delivery systems, announced today that Robert Langer, Sc.D., MIT Institute Professor, and Peter Hunter, Ph.D., University of Auckland Distinguished Professor have joined the company's Scientific Advisory Board.

"We are thrilled to welcome two esteemed biotechnology leaders, Professor Robert Langer and Professor Peter Hunter, to our team," said Dr. Patrick Anquetil, Chief Executive Officer of Portal Instruments. "We will benefit greatly from their combined and extensive expertise in drug delivery, physiological modeling, and medical device development, as we transition our efforts from research and development to clinical studies and future commercialization."

Professors Langer and Hunter will join current Scientific Advisory Board Chair, Ian Hunter, Ph.D., co-founder of Portal Instruments and MIT Hatsopoulos Professor of Mechanical Engineering, as Portal continues to develop a digitally-controlled, needle-free drug injection system to simultaneously transform the delivery of modern medicines and improve the patient experience.

Anquetil continued, "We look forward to the insights and contributions Professors Langer and Hunter will make, to push our device to the next level. We believe their unique perspectives with regard to the intricacies of delivery physiology, design for inherent patient variability, and the implementation of clinical investigations will provide a strong benefit to the company."

About Robert Langer
Dr. Langer, a David H. Koch Institute Professor at MIT, is the only person ever to receive both the United States National Medal of Science and the United States National Medal of Technology and Innovation, as well as being elected to all three United States National Academies. He has also served as a member and Chairman of the Food and Drug Administration's Science Board, its highest advisory board.

He has written more than 1,300 articles and holds nearly 1,100 patents, many of which have been licensed or sublicensed to more than 300 pharmaceutical, chemical, biotechnology, and medical device companies worldwide. Professor Langer has been named one of the 25 most important individuals in biotechnology in the world by both Forbes and BioWorld, and he is recognized as the most cited engineer in history. He has received more than 200 honors and awards, including his recent Queen Elizabeth Prize for Engineering, as well as the Breakthrough Prize, the Wolf Prize in chemistry, the Kyoto Prize, the Charles Stark Draper Prize, the Millennium Technology Prize, and 25 honorary doctorates.

Professor Langer received his B.S. from Cornell University and his Sc.D. from MIT, both in Chemical Engineering, and has been involved in the founding of over 20 biotechnology companies.

About Peter Hunter
Dr. Peter Hunter is currently a Professor of Engineering Science and Director of the Bioengineering Institute at the University of Auckland, Director of the New Zealand Medical Technologies Centre of Research Excellence and Director of Computational Physiology at Oxford University. He holds honorary or visiting Professorships at a number of Universities around the world.

He completed an engineering degree in 1971 in Theoretical and Applied Mechanics at the University of Auckland, New Zealand, a Master of Engineering degree in 1972 on solving the equations of arterial blood flow and a DPhil (Ph.D.) in Physiology at the University of Oxford in 1975 on finite element modeling of ventricular mechanics. His major research interests since then have been modeling many aspects of the human body using specially developed computational algorithms and an anatomical and biophysical-based approach which incorporates detailed microstructural measurements and material properties into the continuum models.

Professor Hunter has received numerous accolades for his work and in 2010 was appointed to the New Zealand (NZ) Order of Merit. In 2009, he was awarded the Rutherford Medal, New Zealand's top science award, as well as the KEA World Class NZ award in Research, Science, Technology and Academia.

He is on the Scientific Advisory Boards of a number of Research Institutes in Europe, the U.S. and the Asia-Pacific region. He is an elected Fellow of the Royal Society (London and NZ), the World Council for Biomechanics, the American Institute for Medical and Biological Engineering, and the International Academy of Medical & Biological Engineering. He is currently President-elect for the World Council of Biomechanics and Chair-Elect for the International Academy of Medical and Biological Engineering (IAMBE).

About Portal Instruments
Portal Instruments is transforming the delivery of modern medicines and enhancing the standard of care for chronic diseases. Portal's unique platform technology is capable of injecting today's new biological drugs, regardless of volume or viscosity, with minimal sensation and time, providing the patient with enabling connectivity to optimize their disease challenges. The computer-controlled delivery technology is silent, innocuous, and highly customizable across a large variety of medical, animal, agricultural, and cosmetic applications. For more information, visit: or follow @portaltx on Twitter.


SOURCE Portal Instruments, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. US Bioservices Expands Access of MyPathpoint Portal to Health Insurers
2. SPAC Internationals Chronic Care Management Physician, Patient and Pharmacy Portals Achieve ONC HIT 2014 Edition Modular EHR Certification from ICSA Labs
3. Global Comprehensive Lopinavir Patent Search Online Portal 2015
4. Philips expands connected health informatics capabilities with launch of IntelliSpace Portal 7.0 at RSNA 2014
5. Philips launches DoseWise Portal at RSNA 2014, industrys first integrated radiation dose management solution for patients and clinicians
6. Mana Healths Patient Portal Achieves Meaningful Use Stage 2 Certification
7. ideaPoint Inc. präsentiert Multi-Sponsor-Portal für Forscheranfragen an fünf globale Studiensponsoren bezüglich Zugang zu Daten aus klinischen Studien
8. ideaPoint, Inc. Announces Launch of Multi-Sponsor Portal Providing Researchers Opportunity to Request Access to Clinical Data from Five Global Study Sponsors
9. New Web Portal Explains The Affordable Care Act - "Obamacare"- For People With HIV
10. Market Disruption Imminent as Hospitals and Physicians Aggressively Adopt Patient Portal Technology
11. Closing the Gap Between Patient Expectations and Patient Portals
Post Your Comments:
(Date:11/16/2019)... ANGELES (PRWEB) , ... November 15, 2019 , ... Cosmetic ... were performed in 2018. While patients continue to undergo cosmetic procedures all throughout the ... by the doctor or the facility, anesthesia fees and the extent of the work ...
(Date:11/15/2019)... ... ... Ahead of what’s expected to be among the most severe flu seasons ... Residences, Fulton County Commissioners Marvin Arrington, Jr. and Natalie Hall, as well as City ... residents ages 65 and older at Baptist Towers (1881 Myrtle Drive, SW, Atlanta, Ga. ...
(Date:11/14/2019)... ... 14, 2019 , ... Liv Foods, Inc. has signed a ... Starting January 2020, all five LivBar flavors will be available at all 23 ... hand-baked energy bar that has gained rapid traction in the market in the ...
Breaking Medicine Technology:
(Date:11/19/2019)... ANGELES (PRWEB) , ... November 19, 2019 , ... ... to announce an exclusive interview with Experience Ancient Seas Founder Lisa ... Seas is a company that creates mineral-rich products that nourish skin with eighty-four ...
(Date:11/19/2019)... Texas (PRWEB) , ... November 19, 2019 , ... ... practice solutions, is proud to announce Karna Morrow, CPC, RCC, CCS-P, as the ... healthcare industry. From leading electronic health record implementations, to providing consulting and training ...
(Date:11/19/2019)... ... November 18, 2019 , ... ... online B2B marketplaces for the scientific and healthcare industries, announced today the ... Business Marketing (previously known as Advantage Business Media) ceased operations after 13 ...
(Date:11/16/2019)... (PRWEB) , ... November 15, 2019 , ... ... adults living with memory impairment, has announced the Best Memory Care Facilities in ... to experts, facility features and amenities. , According to the Alzheimer’s ...
(Date:11/16/2019)... ... November 16, 2019 , ... Uniform Advantage (UA), was ... largest faith-based health systems, as it underwent its brand transition from Adventist Health ... product selection to fitting events to uniform delivery. The scope of the new ...
Breaking Medicine News(10 mins):